Tumor-associated macrophages induce lymphangiogenesis in cervical cancer via interaction with tumor cells

APMIS

Volumn 122, Issue 11, 2014, Pages 1059-1069

  Ding, Hui ^a   Cai, Jing ^a   Mao, Min ^a,b   Fang, Yan ^a   Huang, Zaiju ^a   Jia, Jinghui ^a   Li, Tao ^a   Xu, Linjuan ^a   Wang, Junjie ^a,c   Zhou, Jun ^a   Yang, Qiang ^a   Wang, Zehua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b YANGTZE UNIVERSITY   (China)

^c CHINA THREE GORGES UNIVERSITY   (China)

Author keywords

Cervical cancer; Lymphangiogenesis; Lymphatic metastasis; Macrophage

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 8; MESSENGER RNA; VASCULOTROPIN A; VASCULOTROPIN C;

ADULT; ARTICLE; CANCER CELL; CELL INTERACTION; CELL MIGRATION; CERVICAL CANCER CELL LINE; COCULTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STAINING; STROMA; TUMOR ASSOCIATED LEUKOCYTE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM; GENETICS; HELA CELL LINE; MACROPHAGE; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROCEDURES; TUMOR CELL LINE; UTERINE CERVIX TUMOR;

CELL LINE, TUMOR; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; FEMALE; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-8; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; MACROPHAGES; MIDDLE AGED; RNA, MESSENGER; UTERINE CERVICAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84922061259     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/apm.12257     Document Type: Article

References (23)

1. Aubry K, Barriere G, Chable-Rabinovitch H, Dutour A, Paraf F, Monteil J, et al. Molecular mechanisms regulating the angiogenic phenotype in tumors: clinical impact in the future. Anticancer Res 2007;27:3111-9.
2. Schoppmann SF, Fenzl A, Nagy K, Unger S, Bayer G, Geleff S, et al. VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival. Surgery 2006;139:839-46. doi: S0039-6060(06)00028-6 [pii] 10.1016/j.surg.2005.12.008
3. Dadras SS, Paul T, Bertoncini J, Brown LF, Muzikansky A, Jackson DG, et al. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 2003;162:1951-60. doi: S0002-9440(10)64328-3 [pii] 10.1016/S0002-9440(10)64328-3
4. Ji RC. Macrophages are important mediators of either tumor- or inflammation-induced lymphangiogenesis. CMLS 2012;69:897-914. doi:10.1007/s00018-011-0848-6
5. Maruyama K, Ii M, Cursiefen C, Jackson DG, Keino H, Tomita M, et al. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 2005;115:2363-72. doi:10.1172/JCI23874
6. Kerjaschki D. The crucial role of macrophages in lymphangiogenesis. J Clin Invest 2005;115:2316-9. doi:10.1172/JCI26354
7. Schoppmann SF, Birner P, Stockl J, Kalt R, Ullrich R, Caucig C, et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 2002;161:947-56. doi:S0002-9440(10)64255-1 [pii]10.1016/S0002-9440(10)64255-1
8. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8. doi:10.1056/NEJM199101033240101
9. Sica A, Schioppa T, Mantovani A, Allavena P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 2006;42:717-27. doi:S0959-8049(06)00040-2 [pii]10.1016/j.ejca.2006.01.003
10. Chen JJ, Lin YC, Yao PL, Yuan A, Chen HY, Shun CT, et al. Tumor-associated macrophages: the double-edged sword in cancer progression. J Clin Oncol 2005;23:953-64. doi:JCO.2005.12.172 [pii]10.1200/JCO.2005.12.172
11. Chen JJ, Yao PL, Yuan A, Hong TM, Shun CT, Kuo ML, et al. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. Clin Cancer Res 2003;9:729-37.
12. Tjiu J-W, Chen J-S, Shun C-T, Lin S-J, Liao Y-H, Chu C-Y, et al. Tumor-Associated Macrophage-Induced Invasion and Angiogenesis of Human Basal Cell Carcinoma Cells by Cyclooxygenase-2 Induction. J Invest Dermatol 2008;129:1016-25. doi:10.1038/jid.2008.310
13. Wu H, Xu JB, He YL, Peng JJ, Zhang XH, Chen CQ, et al. Tumor-associated macrophages promote angiogenesis and lymphangiogenesis of gastric cancer. J Surg Oncol 2012;106:462-8. doi:10.1002/jso.23110
14. Achen MG, Jeltsch M, Kukk E, Makinen T, Vitali A, Wilks AF, et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci U S A 1998;95:548-53.
15. Tammela T, Zarkada G, Wallgard E, Murtomaki A, Suchting S, Wirzenius M, et al. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 2008;454:656-60. doi:nature07083 [pii]10.1038/nature07083
16. Cursiefen C, Chen L, Borges LP, Jackson D, Cao J, Radziejewski C, et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 2004;113:1040-50. doi:10.1172/JCI20465
17. Nakao S, Kuwano T, Tsutsumi-Miyahara C, Ueda S, Kimura YN, Hamano S, et al. Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth. J Clin Invest 2005;115:2979-91. doi:10.1172/JCI23298
18. Rosenkilde MM, Schwartz TW. The chemokine system - a major regulator of angiogenesis in health and disease. APMIS 2004;112:481-95. doi:APMapm11207-0808 [pii]10.1111/j.1600-0463.2004.apm11207-0808.x
19. Waugh DJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res 2008;14:6735-41. doi:10.1158/1078-0432.CCR-07-484314/21/6735 [pii]
20. Watari K, Nakao S, Fotovati A, Basaki Y, Hosoi F, Bereczky B, et al. Role of macrophages in inflammatory lymphangiogenesis: enhanced production of vascular endothelial growth factor C and D through NF-kappaB activation. Biochem Biophys Res Commun 2008;377:826-31. doi:S0006-291X(08)02026-3 [pii]10.1016/j.bbrc.2008.10.077
21. Maruyama K, Asai J, Ii M, Thorne T, Losordo DW, D'Amore PA. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol 2007;170:1178-91. doi:S0002-9440(10)61333-8 [pii]10.2353/ajpath.2007.060018
22. Kido S, Kitadai Y, Hattori N, Haruma K, Kido T, Ohta M, et al. Interleukin 8 and vascular endothelial growth factor - prognostic factors in human gastric carcinomas? Eur J Cancer 2001;37:1482-7. doi:S0959-8049(01)00147-2 [pii]
23. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L. The origin and function of tumor-associated macrophages. Immunol Today 1992;13:265-70. doi:0167-5699(92)90008-U [pii]10.1016/0167-5699(92)90008-U